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INTRODUCTION
  The development of a malignant tumor involves 
complex interactions between several factors, both 
exogenous (environmental) and endogenous (genetic, 
hormonal, and immunological). Carcinogenesis often 
proceeds through multiple discernible but overlapping 
stages.1) These include initiation, promotion, pro-
gression and their further evolution to tumors with 
increasing degrees of malignancy. The transitions 
between successive stages can be enhanced or inhib-
ited by various agents. Several types of evidence indi-
cate that 50∼80% of human cancer is potentially 
preventable because its causation is largely exoge-
nous.2) Therefore, recent studies have been focused on 
a new alternative approach referred to as cancer 
chemoprevention, which is defined as the use of 
specific chemical compounds to prevent, inhibit, or 
reverse carcinogenesis.3,4) Natural products, particu-
larly dietary substances-green and black tea poly-
phenols,5) lycopene,6) soy isoflavones,7) curcumin,8) 
phenethyl isothiocyanate (PEITC),9) indol-3-carbinol,10) 
and perillyl alcohol,11) have played an important sole... 
  Xanthorrhizol is a sesquiterpenoid isolated from Curcuma xanthorrhiza that has been 
known to possess anti-inflammatory and anti-carcinogenic effects. In this work, we have 
found that xanthorrhizol reduced superoxide anion generation by 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) in differentiated HL-60 cells and exerted a dose-related 
inhibition of His+ reversion in Salmonella typhimurium TA102 induced by tert-butylhy-
droperoxide (t-BOOH) and hydrogen peroxide. Pretreatment of xanthorrhizol significantly 
decreased the incidence and the multiplicity of mouse skin tumors stimulated by TPA 
for 19 weeks after a single application of dimethylbenz[a]anthracene (DMBA), and miti-
gated the expression of epidermal ornithine decarboxylase in the skins. These results 
demonstrate that xanthorrhizol may be a potent cancer chemopreventive agent.
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other chronic diseases. The majority of naturally 
occurring compounds which possess marked antioxi-
dative and anti-inflammatory properties retain chemo-
preventive or chemoprotective activities as well.12)
  Xanthorrhizol (Fig. 1) isolated from the rhizoma of 
Curcuma xanthorrhiza Roxb (Zingiberaceae) is a com-
pound structurally related to curcumene, the phenolic 
sesquiterpenoid hydrocarbon. C. xanthorrhiza has 
been used in Indonesian folk medicine as chola-
gogues, aromatic stomachics, analgesics and a rheu-
matic remedy.13,14) Antiinflammatory,15,16) antitumor17) 
and hepatoprotective18) activities of the methanolic 
extract of C. xanthorrhiza have also been reported. 
Although many pharmacological effect of the crude 
extract of C. xanthorrhiza have been reported, little 
attention has been paid to the biological activity of 
xanthorrhizol, one of its active principles. We reported 
previously that xanthorrhizol exhibited a potent 
inhibition of cyclooxygenase-2 and inducible nitric 
oxide synthase activity in lipopolysaccharide-stimu-
lated RAW 264.7 cells.19) The present study was 
carried out to elucidate the chemoprotective effect of 
xanthorrhizol. We investigated its effects on (a) 
superoxide anion generation by TPA in differentiated 
HL-60 cells, (b) oxidant-induced bacterial mutagene-
sis and, (c) tumor formation and the expression of 
ornithine decarboxylase (ODC) in two- stage mouse 
skin carcinogenesis model.
MATERIALS AND METHODS
    1) Chemicals
  Xanthorrhizol was supplied from Dr. Jae-Kwan 
Hwang of Department of Biotechnology, Yonsei 
University (Seoul, Korea). NADP+, DMBA, TPA, 
tert-butylhydroperoxide (t-BOOH), dimethylsulfoxide 
(DMSO), glucose 6-phosphate, cytochrome c were 
purchased from Sigma Chemical Co. (St. Louis, MO, 
USA). RPMI 1640, fetal bovine serum (FBS), gen-
tamicin were obtained from Gibco BRL (Grand 
Island, NY, USA). All other chemicals and solvents 
used were commercial products of analytical grade.
    2) Animals
  Female ICR mice (about 6 weeks of age) were 
supplied from DAEHAN Biolink, Co., Ltd. (Chung-
buk, Korea). Mice were fed ad libitum and kept at 
temperature of 22±2oC with a 12 h light/dark cycle.
    3) Measurement of superoxide generation in 
differentiated HL-60 cells
  HL-60 cells were maintained in RPMI 1640 
medium supplemented with 10% heat-inactivated fetal 
bovine serum and 5 g/ml gentamicin as described 
previously.20) The cells were suspended at a density 
of 5×105 cells/ml in RPMI medium containing 10% 
fetal bovine serum and 1.25% DMSO, and incubated 
for 6 days at 37oC in a humidified atmosphere of 5% 
CO2. The cells were harvested by centrifugation, 
washed with and then resuspended in phosphate- 
buffered saline (1×106 cells/ml). The cells were 
preincubated for 10 min with or without xanthorrhizol. 
Reactions were stopped 40 min after the addition of 
TPA (8μM) and cytochrome c (160μM). Control 
cells received PBS instead of TPA. The samples were 
centrifuged to remove the cells before analysis of the 
supernatants at 550 nm.
    4) Ames/Salmonella mutagenicity assay
  The bacterial mutagenicity assays were conducted 
with Salmonella typhimurium TA102 by using the 
liquid pre-incubation method developed by Maron and 
Ames.21) Briefly, S. typhimurium TA102 were grown 
in Oxoid nutrient broth medium. 100μl of an 11-h 
culture of S. typhimurium TA102 was added to 600μl 
of the mixture containing hydrogen peroxide (50 
Fig. 1. The structure of xanthorrhizol isolated from Cur-
cuma xanthorrhiza.
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g/plate) and t-BOOH (100 g/plate) in the presence or 
absence of a given xanthorrhizol. After pre-incubation 
for 30 min at 37oC in a rotary shaker, the mixture was 
transferred to 2 ml top agar containing 0.5 mM 
histidine-biotin (all kept warm at 45oC) and poured 
onto minimal glucose plates. The plates were 
incubated for 48 h at 37oC and the number of His+ 
revertant colonies was counted.
    5) Two-stage mouse skin carcinogenesis
  The dorsal regions of 6-week-old female ICR mice 
(30 per group) were shaved with an electric clipper. 
The mice were treated topically with a single dose of 
0.2μmol DMBA, and one week later, 7.5 nmol of 
TPA in 0.2 ml of acetone was topically applied three 
times weekly for 19 weeks. When necessary, 2μmol 
and 6μmol of xanthorrhizol in 0.2 ml of acetone- 
DMSO (85：15, v/v) were applied topically 30 min 
prior to TPA treatment. Tumors of at least 1 mm in 
diameter were counted and recorded biweekly. The 
results are expressed as the average number of tumors 
per mouse and percentage of tumor-bearing mice. The 
mice were sacrificed by cervical dislocation at 19 
week and the skin was excised. The skin was stored 
at -80oC for molecular analyses.
    6) Western blot analysis of mouse epidermal 
ODC
  The frozen skin described above was pulverized 
with mortar in liquid N2 after the fat removed. The 
pulverized mouse skin was lysed in 300μl of ice- 
chilled lysis buffer [20 mM Tris-HCl (pH 7.5), 150 
mM NaCl, 1 mM Na2EDTA, 1mM EGTA, 1% Triton, 
2.5 mM sodium pyrophosphate, 1 mM β-glycero-
phosphate, 1 mM Na3VO4, 1 g/ml leupeptin] for 1 hr. 
Lysates were centrifuged at 15,000 rpm for 10 min, 
and aliquots of supernatant containing 20μg protein 
were boiled in SDS sample loading buffer for 5 min 
before electrophoresis on a 10% SDS-polyacrylamide 
gel. Blots were transferred from SDS-polyacrylamide 
gel to PVDF membrane (Amersham, Arlington 
Heights, IL), blocked with 5% fat-free dry milk-PBST 
(phosphate buffered saline containing 0.1% Tween-20) 
buffer for 2 hr at room temperature and then washed 
in PBST buffer. Membrane was incubated overnignt 
at 4oC with a 1：1,000 dilution of mouse ODC 
monoclonal antibody (Sigma-Aldrich). Blots were 
rinsed with PBST, incubated overnight with a 1：
5,000 dilution of anti-mouse horseradish peroxidase- 
conjugated secondary antibody at 4oC and then 
washed again three times in PBST buffer for 5 min. 
Transferred proteins were visualized with an ECL 
detection kit (Santa Cruz Biotechnology, Santa Cruz, 
CA), according to the manufacturer's procedures.
RESULTS AND DISCUSSION
  To meet the desired goal of widespread imple-
mentation of chemoprevention of cancer, progress will 
need to occur in four major areas: enlargement of 
basic scientific knowledge of mechanisms of carcino-
genesis, clinical studies to validate specific pharma-
cological agents for chemoprevention of human can-
cer, development of new and better agents for even-
tual use for chemoprevention in men and women, and 
a more broadly based educational effort by both 
physicians and society to achieve better understanding 
and compliance with the goals of chemoprevention.22) 
Recently, considerable attention has been focused on 
naturally occurring phytochemicals which exist in 
medicinal or edible plants as good sources to derive 
new chemopreventive agents. The phenolic com-
pounds with antioxidative and anti-inflammatory acti-
vities has anticipated to exert chemopreventive effects 
in carcinogenesis, particularly in the promotion stage.
  Reactive oxygen species (ROS) from both endo-
genous and exogenous sources can cause inflam-
mation, oxidative DNA damage and dysregulated cell 
signaling, which are involved in the multistage 
process of carcinogenesis such as tumor initiation, 
promotion and progression. TPA-induced tumor 
promotion is best correlated with epidermal ODC 
activity and inflammation reactions such as hyper-
plasia, neutrophil infiltration and H2O2 formation in 
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mouse skin.23) Among inflammatory cells, neutrophils 
are particularly adept at generating and releasing ROS 
such as superoxide anion, hydrogen peroxide, 
hypochlorous acid, singlet oxygen and hydroxyl 
radical. Excessive ROS released from neutrophils is 
closely associated with the metabolic activation of 
proximate carcinogens,24) increase the levels of 
oxidized DNA bases25) and enhance ODC activity.26) 
Thus, the regulation of ROS from activated leukocytes 
is proposed to be one of the most promising strategies 
for cancer control. Although antioxidants inhibit 
tumor initiation by procarcinogens, they can more 
effectively suppress tumor promotion associated with 
inflammation by inhibiting leukocyte-derived ROS 
generation.27)
  As shown in Fig. 2, xanthorrhizol reduced the 
generation of superoxide anion by TPA stimulation in 
differentiated HL-60 cells in a dose dependent 
manner. Xanthorrhizol significantly blocked His+ 
reversion in S. typhimurium TA102 induced by 50μg 
of hydrogen peroxide (Table 1) and 100μg of 
t-BOOH (Table 2), which is an organic hydroperoxide 
that generates oxygen radicals under physiological 
conditions and acts as a tumor promoter in mouse 
Table 1. The inhibitory effects of xanthorrhizol on the muta-
genesis induced by hydrogen peroxide in S. typhimurium 
TA102
ꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧ
Xanthorrhizol His+ revertants/platea % inhibition(nmol/plate)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
0 219±30 
2 188±23 14
4 174±27b 21
8 133±9c  39
10 79±16c 64
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
aEach data represent the mean±SE from triplicate plates.
*Significantly different from the plates treated with hydro-
gen peroxide without xanthorrhizol (bP＜0.05, cP＜0.01)
Table 2. The inhibitory effects of xanthorrhizol on the muta-
genesis induced by t-BOOH in S. typhimurium TA102
ꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧ
Xanthorrhizol His+ revertants/plate % inhibition(nmol/plate)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
0 594±29 
10 309±78b 48
20 234±2c  61
40 23±14c 96
60 7±7c 99
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
aEach data represent the mean±SE from triplicate plates.
*Significantly different from the plates treated with t- 
BOOH without xanthorrhizol (bP＜0.05, cP＜0.00005)
Fig. 2. Inhibitory effects of xanthorrhizol on TPA-stimul-
ated superoxide anion generation in differentiated HL-60 
cells. Xanthorrhizol was preincubated at the indicated con-
centration for 10 min with the cells differentiated with 
1.25% DMSO prior to addition of TPA (8μM). Super-
oxide anion generation was determined 30 min after the 
TPA treatment.
Fig. 3. Experimental protocols for evaluation of the che-
moprotective effect against DMBA-induced mouse skin 
carcinogenesis. Female ICR mice were given 0.2μmol 
DMBA in 0.2 ml of acetone-DMSO (85：15) followed by 
topical application of 7.5 nmol TPA in 0.2 ml of ace-
tone-DMSO (85：15), twice a week for 19 weeks. Some 
animals received 2 and 6 μmol xanthorrhizol in 0.2 ml of 
acetone-DMSO (85：15) before TPA treatment.
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skin.28) These antioxidative and antimutagenic activi-
ties of xanthorrhizol were more excellent than those 
of curcumin (data not shown).
  All of the mice treated with 7.5 nmol TPA three 
times weekly for 19 weeks after initiation with a 
single dose of 0.2μmol DMBA developed the average 
number of 15.5 skin tumors per animal (Fig. 3 and 
Table 3). Mice given topical application of 2 and 6 
μmol xanthorrhizol during tumor promotion developed 
an average of 6.9 and 4.0 skin tumors per animal with 
80% and 57% tumor incidences, respectively. ODC 
expression (Fig. 4) was markedly reduced in mice 
applied topically by xanthorrhizol.
  Taken together, xanthorrhizol is a good ROS 
scavenger and a potent inhibitor on oxidant-induced 
bacterial mutagenesis. Moreover, xanthorrhizol signi-
ficantly suppressed tumor promotion and ODC expres-
sion in mouse skin stimulated with TPA. These results 
demonstrate that xanthorrhizol possesses substantial 
chemopreventive activity.
ACKNOWLEDGEMENT
  This work was supported by Yonsei University 
Research Fund of 2002.
REFERENCES
 1) Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP. 
Multistage carcinogenesis. In: Seije M and Bernstein 
IA Biochemistry of normal and abnormal epidermal 
differentiation. pp 19-38, Tokyo: University of Tokyo 
Press, 1980.
 2) Flora RH, Bennicelli C, Bagnasco M. Rationale and 
mechanisms of cancer chemoprevention. In: Senn 
H.-J., Costa A and Jordan VC Chemoprevention of 
cancer, pp 29-44, Springer-Verlag, Berlin, Heidelberg, 
1999.
 3) Kelloff GJ, Hawk ET, Karp JE, Crowell JA, Boone 
CW, Steele VE, Lubet RA, Sigman CC. Progress in 
clinical chemoprevention. Semin Oncol 1997; 24: 
241-252.
 4) Hong WK, Sporn MB. Recent advances in chemopreven-
tion of cancer. Science 1997; 278: 1073-1077.
 5) Huang MT, Ho CT, Wang ZY, Ferraro T, Finnegan- 
Olive T, Lou YR, Mitchell JM, Laskin JD, Newmark 
H, Yang CS, Conney AH. Inhibitory effect of topical 
application of a green tea polyphenol fraction on 
tumor initiation and promotion in mouse skin. Car-
cinogenesis 1992; 13: 947-954.
 6) Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, 
Colditz GA, Willett WC. Intake of carotenoids and 
retinol in relation to risk of prostate cancer. J Natl 
Cancer Inst  1995; 87: 1767-1776.
 7) Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet 
RA, Boone CW, Covey JM, Doody LA, Omenn GS, 
Greenwald P, Hong WK, Parkinson DR, Bagheri D, 
Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, 
Johnson K, Longfellow DG, Knapp GG, Malone WF, 
Table 3. The protective effects of xanthorrhizol against 
DMBA-initiated and TPA-promoted two-stage mouse skin 
carcinogenesis
ꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧꠧ
No. of Tumor-bearingTreatmenta tumors/mouse mice (%)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
DMBA-TPA 15.5±2.3 100
DMBA-XT (2μmol)-TPA 6.9±1.1b  80
DMBA-XT (6μmol)-TPA 4.0±1.1b  57
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
a2 or 6μmol of xanthorrhizol (XT) was applied topically 
to female ICR mice 30 min prior to topical application 
of 7.5 nmol TPA for 19 weeks.
*Significantly different from the values observed in the 
group given TPA alone (P＜0.005)
Fig. 4. Effect of xanthorrhizol on ODC expression in 
mouse skin treated with TPA for 19 weeks after a single 
topical dose of DMBA. Dorsal skins of female ICR mice 
were treated with 0.2 ml of acetone-DMSO (85：15, lane 
1) and 7.5 nmol TPA in 0.2 ml of acetone (lane 2). For 
some animals, 2μmol (lane 3) and 6μmol (lane 4) of 
xanthorrhizol was given topically 30 min before TPA (7.5 
nmol) for 19 weeks. ODC protein was derermined by 
immunoblot analysis, as described under Material and 
Methods.
Xanthorrhizol
ODC
β-actin
Vehicle 0 2.0 6.0 µmol
TPA
96  대한암예방학회지：제 8 권 제 2 호 2003
Nayfield SG, Seifried HE, Swall LM, Sigman CC. 
Clinical development plan: Genistein. J Cell Biochem 
Suppl 1996; 26: 114-126. 
 8) Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet 
RA, Boone CW, Covey JM, Doody LA, Omenn GS, 
Greenwald P, Hong WK, Parkinson DR, Bagheri D, 
Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, 
Johnson K, Longfellow DG, Knapp GG, Malone WF, 
Nayfield SG, Seifried HE, Swall LM, Sigman CC. 
Clinical development plan: Curcumin. J Cell Biochem 
Suppl 1996; 26: 72-85.
 9) Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet 
RA, Boone CW, Covey JM, Doody LA, Omenn GS, 
Greenwald P, Hong WK, Parkinson DR, Bagheri D, 
Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, 
Johnson K, Longfellow DG, Knapp GG, Malone WF, 
Nayfield SG, Seifried HE, Swall LM, Sigman CC. 
Clinical development plan: Phenethyl isothiocyanate 
(PEITC). J Cell Biochem Suppl 1996; 26: 149-157.
10) Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet 
RA, Boone CW, Covey JM, Doody LA, Omenn GS, 
Greenwald P, Hong WK, Parkinson DR, Bagheri D, 
Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, 
Johnson K, Longfellow DG, Knapp GG, Malone WF, 
Nayfield SG, Seifried HE, Swall LM, Sigman CC. 
Clinical development plan: Indole-3-carbinol. J Cell 
Biochem Suppl 1996; 26: 127-136.
11) Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet 
RA, Boone CW, Covey JM, Doody LA, Omenn GS, 
Greenwald P, Hong WK, Parkinson DR, Bagheri D, 
Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, 
Johnson K, Longfellow DG, Knapp GG, Malone WF, 
Nayfield SG, Seifried HE, Swall LM, Sigman CC. 
Clinical development plan: Perillyl alcohol. J Cell 
Biochem Suppl 1996; 26: 137-148.
12) Surh YJ. Molecular mechanisms of chemopreventive 
effects of selected dietary and medicinal phenolic 
substances. Mutation Res 1999; 428: 305-327.
13) Kasahara YS, Mangunkawatja S. Medicinal herb in-
dex in indonesia. PT Eisai, Indonesia, 1986; p 343.
14) Elliott S, Brimacombe J. The medicinal plants of 
Gunung Leuser National Park, Indonesia. J Ethno-
pharmacol 1987; 19: 285-317.
15) Ozaki Y. Antiimflammatory effect of curcuma xanthor-
rhiza roxb. and its active principles. Chem Pharm Bull 
(Tokyo) 1990; 38: 1045-1048.
16) Claeson P, Panthong A, Tuchinda P, Reutrakul V, 
Kanjanapothi D, Taylor WC. Three non-phenolic dia-
rylheptanoids with anti-inflammatory activity from 
Curcuma xanthorrhiza. Planta Med 1993; 59: 451-454.
17) Itokawa H, Hirayama F, Funakoshi K, Takeya K. 
Studies on the antitumor bisabolane sesquiterpenoids 
isolated from Curcuma xanthorrhiza. Chem Pharm 
Bull 1985; 33: 3488-3492.
18) Lin SC, Lin CC, Lin YH, Supriyatna S, Teng CW. 
Protective and therapeutic effects of curcuma xanthor-
rhiza on hepatotoxin-induced liver damage. Am J Chin 
Med 1995; 23: 243-254. 
19) Lee SK, Hong CH, Huh SK, Kim SS, Oh OJ, Min 
HY, Park KK, Chung WY, Hwang JK. Suppressive 
effect of natural sesquiterpenoids on inducible cyclo-
oxygenase (COX-2) and nitric oxide synthase (iNOS) 
activity in mouse macrophage cells. J Environ Pathol 
Toxicol Oncol 2002; 21: 141-148.
20) Chun KS, Sohn Y, Kim HS, Kim OH, Park KK, Lee 
JM, Lee J, Lee JY, Moon A, Lee SS, Surh YJ. 
Anti-tumor promoting potential of naturally occurring 
diarylheptanoids structurally related to curcumin. 
Mutat Res 1999; 428: 49-57. 
21) Maron DM, Ames BN. Revised methods for the sal-
monella mutagenicity test. Mutation Res 1983; 113: 
173-215.
22) Albers DS, Colvin OM, Conney AH, Ernster VL, Gar-
ber JE, Greenwald P, Gudas LJ, Hong WK, Kelloff 
GJ, Kramer RA, Lerman CE, Mangelsdorf DJ, Matter 
A, Minna JD, Nelson V WG, Pezzuto JM, Prendergast 
F, Rusch VW, Sporn MB, Wattenberg LW, Weinstein 
IB. Prevention of cancer in the next millennium: 
Report of the Chemoprevention Working Group to the 
American Association for Cancer Research. Cancer 
Res 1999; 59: 4743-58.
23) Wang CJ, Lee MJ, Chang MC, Lin JK. Inhibition of 
tumor promotion in benzo[a]pyrene-initiated CD-1 
mouse skin by crocetin. Carcinogenesis 1995; 16:  
187-191.
24) Kensler TW, Egner PA, Moore KG, Taffe BG, Twer-
dok LE, Trush MA. Role of inflammatory cells in the 
metabolic activation of polycyclic aromatic hydrocar-
bons in mouse skin. Toxicol Appl Pharmacol 1987; 
90: 337-346.
25) Wei H, Frenkel K. Relationship of oxidative events 
and DNA oxidation in SENCAR mice to in vivo pro-
moting activity of phorbol ester-type tumor promoters. 
Carcinogenesis 1993; 14: 1195-1201.
26) Wei H, Frenkel K. Suppression of tumor promoter- 
induced oxidative events and DNA damage in vivo by 
sarcophytol A: a possible mechanism of antipromo-
tion. Cancer Res 1992; 52: 2298-2303.
Jae-Hee Park, et al：Chemopreventive Effect of Xanthorrhizol from Curcuma xanthorrhiza  97
27) Nakamura Y, Ohto Y, Murakami A, Osawa T, Ohi-
gashi H. Inhibitory effects of curcumin and tetrahy-
drocurcuminoids on the tumor promoter-induced reac-
tive oxygen species generation in leukocytes in vitro 
   and in vivo. Jpn J Cancer Res 1998; 89: 361-370.
28) Epe B, Hegler J, Wild D. Identification of ultimate 
DNA-damaging oxygen species. Environ Health Pers-
pect 1990; 88: 111-115.
